US Patent Issued to RINUAGENE BIOTECHNOLOGY, RINUAGENE INTERNATIONAL HK on June 3 for "Polynucleotide molecules used for the prevention or treatment of HPV infection related diseases" (Chinese Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,441, issued on June 3, was assigned to RINUAGENE BIOTECHNOLOGY Co. LTD. (Suzhou, China) and RINUAGENE INTERNATIONAL HK Ltd. (Hong Kong).

"Polynucleotide molecules used for the prevention or treatment of HPV infection related diseases" was invented by Shan Cen (Suzhou, China), Jing Wang (Suzhou, China), Weiguo Zhang (Suzhou, China) and Yijie Dong (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a polynucleotide molecule that can be used for preventing or treatment HPV infection-related diseases, and a pharmaceutical product, a pharmaceutical composition, or an mRNA vaccine comprising said polynucleotide....